Patients with multiple myeloma that exhibit increased Serum free light chains may be efficiently demonstrated to have these abnormal free serum light chains by which of the following techniques?

Question

Quizplus · Accepted Answer

Serum free light chain immunoassay is specifically designed to detect abnormal levels of free light chains in the serum, which is a common finding in patients with multiple myeloma. This makes it an efficient technique for demonstrating these abnormalities.

Patients with Multiple Myeloma That Exhibit Increased Serum Free Light